COVID-19 and Menstrual-related Disturbances: a Spanish Retrospective Observational Study in Formerly Menstruating Women

Overview

Journal Front Glob Womens Health

Specialty Public Health

Date 2024 Aug 14

PMID 39140011

Authors

Maria Gonzalez

Miriam Al-Adib

Ana B Rodriguez

Cristina Carrasco

Affiliations

Soon will be listed here.

Abstract

Introduction: Four years after the start of the pandemic, there is limited evidence on the impact of COVID-19 on the women's health regardless of their reproductive status.

Objective: The aim was to analyze the prevalence and associated factors of menstrual-related disturbances in formerly menstruating women following SARS-CoV-2 infection.

Study Design: A retrospective observational study of adult women in Spain was conducted during the month of December 2021 using an online survey ( = 17,512). The present analysis includes a subpopulation of SARS-CoV-2-infected and formerly menstruating women ( = 72). The collected data included general characteristics, medical history, and specific information on COVID-19. Chi-square and Mann-Whitney -tests were performed. Bivariate logistic regression analysis was then performed to investigate possible associations between the occurrence of menstrual-related disturbances after SARS-CoV-2 infection.

Results: 38.8% of participants experienced menstrual-related disturbances following COVID-19. Among these, unexpected vaginal bleeding (20.8%) was the most common event, followed by spotting (11.1%) ( Table 1). Other reported changes were in the length (shorter = 12.5%) and flow (heavier = 30.3%) of menstrual bleeding in comparison to their previous experience. Regression analysis revealed that being a perimenopausal woman [adjusted odds ratio (AOR) 4.721, CI 95%, 1.022-21.796, = 0.047] and having a previous diagnosis of menorrhagia (AOR 5.824 CI 95%, 1.521-22.310, = 0.010) were factors associated with the event.

Conclusion: These findings could help health professionals provide their patients with up-to-date scientific information to empower them to actively manage their reproductive health, especially in societies where menstrual health is still taboo.

References

Sweet M, Schmidt-Dalton T, Weiss P, Madsen K . Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2012; 85(1):35-43. View

Bechmann N, Maccio U, Kotb R, Al Dweik R, Cherfane M, Moch H . COVID-19 Infections in Gonads: Consequences on Fertility?. Horm Metab Res. 2022; 54(8):549-555. PMC: 9363149. DOI: 10.1055/a-1891-6621. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Reis F, Reis A . Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions. Clin Sci (Lond). 2020; 134(22):2929-2941. DOI: 10.1042/CS20200865. View

Li J, Bai J, Xiang X, Guo Y, Yu H . Effect of COVID-19 on Menstruation and Lower Reproductive Tract Health. Int J Womens Health. 2023; 15:1999-2013. PMC: 10752023. DOI: 10.2147/IJWH.S433516. View

Kurmanova A, Kurmanova G, Lokshin V . Reproductive dysfunctions in viral hepatitis. Gynecol Endocrinol. 2016; 32(sup2):37-40. DOI: 10.1080/09513590.2016.1232780. View

Wu M, Ma L, Xue L, Zhu Q, Zhou S, Dai J . Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age. Genomics. 2021; 113(6):3449-3460. PMC: 8372464. DOI: 10.1016/j.ygeno.2021.08.012. View

Kirtipal N, Kumar S, Dubey S, Dwivedi V, Gireesh Babu K, Maly P . Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect Genet Evol. 2022; 99:105254. PMC: 8863418. DOI: 10.1016/j.meegid.2022.105254. View

Khan S, Shilen A, Heslin K, Ishimwe P, Allen A, Jacobs E . SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am J Obstet Gynecol. 2021; 226(2):270-273. PMC: 8452349. DOI: 10.1016/j.ajog.2021.09.016. View

10.

Carp-Veliscu A, Mehedintu C, Frincu F, Bratila E, Rasu S, Iordache I . The Effects of SARS-CoV-2 Infection on Female Fertility: A Review of the Literature. Int J Environ Res Public Health. 2022; 19(2). PMC: 8775865. DOI: 10.3390/ijerph19020984. View

11.

Costeira R, Lee K, Murray B, Christiansen C, Castillo-Fernandez J, Ni Lochlainn M . Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study. PLoS One. 2021; 16(9):e0257051. PMC: 8432854. DOI: 10.1371/journal.pone.0257051. View

12.

Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie S, Horne A . The role of infection in miscarriage. Hum Reprod Update. 2015; 22(1):116-33. PMC: 4664130. DOI: 10.1093/humupd/dmv041. View

13.

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

14.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

15.

Khan N . Possible protective role of 17β-estradiol against COVID-19. J Allergy Infect Dis. 2020; 1(2):38-48. PMC: 7665224. DOI: 10.46439/allergy.1.010. View

16.

Schoenbaum E, Hartel D, Lo Y, Howard A, Floris-Moore M, Arnsten J . HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005; 41(10):1517-24. DOI: 10.1086/497270. View

17.

Amer A, Amer S, Alrufaidi K, Abd-Elatif E, Alafandi B, Yousif D . Menstrual changes after COVID-19 vaccination and/or SARS-CoV-2 infection and their demographic, mood, and lifestyle determinants in Arab women of childbearing age, 2021. Front Reprod Health. 2022; 4:927211. PMC: 9580647. DOI: 10.3389/frph.2022.927211. View

18.

Suba Z . Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci. 2020; 23(1):75-85. DOI: 10.18433/jpps31069. View

19.

Ho J, Sepand M, Bigdelou B, Shekarian T, Esfandyarpour R, Chauhan P . The immune response to COVID-19: Does sex matter?. Immunology. 2022; 166(4):429-443. PMC: 9111683. DOI: 10.1111/imm.13487. View

20.

Mateus D, Sebastiao A, Carrascal M, do Carmo A, Matos A, Cruz M . Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection. Rev Med Virol. 2021; 32(3):e2290. PMC: 8646421. DOI: 10.1002/rmv.2290. View